V Valero Selected Research

V Valero Research Topics

Disease

35	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2000
30	Neoplasms (Cancer) 01/2021 - 02/2000
4	Pathologic Complete Response 01/2017 - 06/2004
3	Triple Negative Breast Neoplasms 01/2018 - 06/2014
3	Neoplasm Metastasis (Metastasis) 09/2016 - 02/2001
3	Disease Progression 08/2001 - 12/2000
3	Fever (Fevers) 02/2001 - 01/2000
2	Neutropenia 01/2017 - 01/2000
2	Inflammatory Breast Neoplasms 01/2016 - 10/2001
2	Circulating Neoplastic Cells 05/2012 - 01/2010
2	Lacrimal Apparatus Diseases (Epiphora) 02/2002 - 05/2001
2	Pathologic Constriction (Stenosis) 02/2002 - 05/2001
2	Ovarian Neoplasms (Ovarian Cancer) 07/2001 - 11/2000
1	Residual Neoplasm 01/2021
1	Calcinosis 01/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018
1	Edema (Dropsy) 09/2015
1	Brain Neoplasms (Brain Tumor) 12/2010
1	Colorectal Neoplasms (Colorectal Cancer) 08/2005
1	Carcinoma (Carcinomatosis) 12/2001
1	Cardiotoxicity 08/2001
1	Cardiomyopathies (Cardiomyopathy) 08/2001
1	Fibrosis (Cirrhosis) 05/2001
1	Margins of Excision 04/2001
1	Fatigue 02/2001
1	Myalgia 02/2001
1	Lymphadenopathy 02/2001
1	Stomatitis 01/2001
1	Arthralgia (Joint Pain) 11/2000
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2000
1	Endometrial Neoplasms (Endometrial Cancer) 05/2000
1	Pain (Aches) 04/2000

Drug/Important Bio-Agent (IBA)

10	Paclitaxel (Taxol)FDA LinkGeneric 09/2015 - 11/2000
8	AnthracyclinesIBA 01/2021 - 02/2000
7	Hormones (Hormone)IBA 01/2021 - 04/2006
6	Trastuzumab (Herceptin)FDA Link 09/2016 - 01/2001
6	Estrogen ReceptorsIBA 07/2011 - 02/2000
6	Docetaxel (Taxotere)FDA Link 02/2002 - 01/2000
5	taxaneIBA 01/2021 - 08/2001
5	Vinorelbine (Navelbine)FDA LinkGeneric 02/2001 - 01/2000
4	Taxoids (Taxanes)IBA 07/2008 - 11/2000
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2004 - 01/2000
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2004 - 01/2001
3	Biological ProductsIBA 01/2016 - 07/2001
3	Tamoxifen FDA LinkGeneric 02/2001 - 02/2000
2	human ERBB2 proteinIBA 01/2021 - 01/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 06/2014 - 01/2001
2	Fluorouracil (Carac)FDA LinkGeneric 06/2004 - 12/2001
2	Pharmaceutical PreparationsIBA 10/2001 - 05/2001
2	Gemcitabine FDA Link 03/2001 - 01/2001
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2001 - 01/2000
1	Estrogens (Estrogen)FDA Link 01/2021
1	Aurora Kinase AIBA 01/2021
1	talazoparibIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2015
1	Bevacizumab (Avastin)FDA Link 09/2015
1	onartuzumabIBA 09/2015
1	Everolimus FDA Link 06/2014
1	CaspasesIBA 07/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2010
1	FluorineIBA 01/2010
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2008
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2008
1	Imatinib Mesylate (Gleevec)FDA Link 10/2008
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2008
1	larotaxelIBA 07/2008
1	gamma-Aminobutyric Acid (GABA)IBA 12/2005
1	OligonucleotidesIBA 12/2005
1	GABA-A Receptors (GABA(A) Receptor)IBA 12/2005
1	Biomarkers (Surrogate Marker)IBA 12/2005
1	Capecitabine (Xeloda)FDA Link 08/2005
1	RNA (Ribonucleic Acid)IBA 06/2004
1	Complementary DNA (cDNA)IBA 06/2004
1	Tumor Biomarkers (Tumor Markers)IBA 12/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2001
1	3- (N- (N',N'- dimethylaminoethane)carbamoyl)cholesterolIBA 07/2001
1	Liposomes (Liposome)IBA 07/2001
1	AntibodiesIBA 05/2001
1	Antineoplastic Agents (Antineoplastics)IBA 05/2001
1	SiliconesIBA 05/2001
1	liposomal doxorubicin (Doxil)FDA Link 03/2001
1	Epirubicin (Ellence)FDA LinkGeneric 01/2001
1	Monoclonal AntibodiesIBA 01/2001
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2001
1	PlatinumIBA 11/2000
1	Platinum Compounds (Compounds, Platinum)IBA 11/2000

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2021 - 01/2000
14	Therapeutics 01/2021 - 01/2000
10	Neoadjuvant Therapy 01/2018 - 02/2001
7	Radiotherapy 04/2012 - 02/2000
2	Drug Tapering 01/2017 - 01/2001
1	Duration of Therapy 02/2002
1	Adjuvant Chemotherapy 04/2001
1	Combined Modality Therapy 02/2001
1	Palliative Care (Palliative Therapy) 01/2001
1	Segmental Mastectomy (Lumpectomy) 05/2000
1	Pain Management 04/2000